Welcome!
Home paediatrics
Broker's Calls
KGI Securities initiates coverage on Singapore O&G at 'neutral' on affected earnings due to Covid-19, and falling birth rates
“We highlight the key risks as a basis for our ‘neutral’ rating despite the inherent upside, and will re-evaluate our forecasts after 1H20 results,” say analysts Amirah Yusoff and Joel Ng in a Friday report.
July 03, 2020
RHB strategy for 2017
Singapore Medical Group’s expansion into Vietnam market is just the beginning
SINGAPORE (Jan 10): RHB is maintaining its “buy” call on Singapore Medical Group (SMG) with a target price of 63 cents following the recent news of the group’s expansion into Vietnams’ private healthcare market.
January 10, 2017